Model Virus Selection is the systematic process of choosing representative viral surrogates that match the physicochemical and biological characteristics of relevant viruses to evaluate the effectiveness of viral clearance methods in biopharmaceutical manufacturing.
3
Publications
58
Citations
21
Authors
9
Institutions
Publications per year
2017–2026
1
Parents
Publications
3
1–3 of 3
Authors
21
- UO
1
h-index
- SR
1
h-index
- LA
1
h-index
- IS
1
h-index
- WD
1
h-index
1–5 of 21
Institutions
9
Wageningen University & Research
Wageningen, The Netherlands
1 h-index
1 publications
16 citations
Universidad Autónoma de Madrid
Madrid, Spain
1 h-index
2 publications
32 citations
Baylor College of Medicine
Houston, United States
1 h-index
3 publications
96 citations
Boehringer Ingelheim (France)
Paris, France
1 h-index
1 publications
16 citations
BioPharm (United Kingdom)
Beaconsfield, United Kingdom
1 h-index
3 publications
48 citations
Utrecht University
Utrecht, The Netherlands
1 h-index
2 publications
32 citations
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
1 h-index
7 publications
112 citations
Centro Nacional de Biotecnología
Madrid, Spain
1 h-index
2 publications
32 citations
1–8 of 9
Venues
- mAbs
1 publications · 16 citations
1
h-index
- Cold Spring Harbor Symposia on Quantitative Biology
1 publications · 32 citations
1
h-index
- BioProcessing Journal
1 publications · 10 citations
1
h-index
1–3